Furthermore, they have also been shown to have osteoporosis prevention and liver-protection activities as well as antagonistic activity toward platelet-activating factor (PAF; Han et al., 1992; Habauzit and Horcajada, 2008). The gene discussed is PCLAF; the disease is osteoporosis.